Cargando…
SLC25A10 performs an oncogenic role in human osteosarcoma
Osteosarcoma is one of the most common primary malignant bone tumors in adolescents. It is associated with high risk of relapse and the outcomes of patients with high-grade osteosarcoma remain poor. Therefore, additional studies investigating the molecular mechanisms involved in tumor initiation, gr...
Autores principales: | Wang, Gaoyuan, Xia, Jianjun, Chen, Cheng, Qiu, Jie, Sun, Po, Peng, Zhiwei, Chen, Xiaoyu, Xu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405602/ https://www.ncbi.nlm.nih.gov/pubmed/32774476 http://dx.doi.org/10.3892/ol.2020.11863 |
Ejemplares similares
-
SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway
por: Chen, Ming-Wei, et al.
Publicado: (2018) -
A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancer
por: You, Xin, et al.
Publicado: (2023) -
MiR-25-3p Serves as an Oncogenic MicroRNA by Downregulating the Expression of Merlin in Osteosarcoma
por: Rao, Hua-chun, et al.
Publicado: (2020) -
The mitochondrial carrier SLC25A10 regulates cancer cell growth
por: Zhou, Xiaoshan, et al.
Publicado: (2015) -
An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis
por: Chen, Yan-Jie, et al.
Publicado: (2022)